+
Site Tour

Dr Ingo Eitel explains why LAAO can be an option in ESKD patients

Dr Ingo Eitel explains why left atrial appendage occlusion can be an option in end stage kidney disease (ESKD) patients 

LEARN MORE:

Amplatzer LAA Occluder

Related Videos

Go with the flow A. Cook & D. Arzamendi & J.Mill

LAAO Summit - Imaging debate: Mini TEE

Grill the expert: LAAO beyond bleeding I. Eitel

LAAO Summit - Decoding DRT patient factors

Debate: Concomitant PFA & LAAO M. Gunawardene & T.Zeus

LAAO Summit - LAA anatomy focusing

Leaks: To close or not to close?

LAAO Summit - Imaging debate: ICE

TRENDING TOPICS

HFA Tutorials 2025 I.Stankovic

HFA Tutorials 2025
STRAIN and echo workshop | How to assess an HF patient

HFA Tutorial 2025 E.Donal | Case based

HFA Tutorials 2025
Case based | How to manage a Secondary AV valve disease, with a focus on Tricuspid

HFA Tutorials 2025 E.Donal

HFA Tutorials 2025
Simulation & Hands-on | How to treat an HF patient with the TEER therapy

CONNEXT


HUB
RELATED RESOURCES

Amplatzer™ Amulet™ LAA Occluder

Monitoring for AF prior to PFO closure

The Amulet IDE Trial

CONNEXT


LIVE
RELATED EVENTS

LAAO Summit - Ideal vs suboptimal LAAO implant

LAAO Summit 2023: Stroke severity

LAAO Summit - Debate: Factor XI inhibitors

LAAO Summit - Device placement and DRT

You are about to leave my-connext.com

You are now leaving my-connext.com. Abbott is not responsible for any content published on the third-party website you are about to enter. Abbott has not reviewed and does not endorse any information presented on third-party websites.

The content on this website is intended for healthcare professionals in EMEA with applicable health authority product registrations, excepted those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011 article 34. Click OK to confirm you are a healthcare professional to proceed.

OK Decline